News ArticleMore News »
Novum To Attend DIA 2016 Annual Conference
May 30, 2016
Pittsburgh, PA: Members of Novum’s Scientific Affairs team, lead by Ms. Pina D’Angelo, MSc, Senior Director, Scientific Affairs (Biostatistics) will be in attendance at the upcoming 52nd DIA Annual Meeting from June 26th – 30th. Her team has been accepted as a professional poster presentation on the topic of “Testing for Bioequivalence in Higher-Order Crossover Designs: Two-at-a-Time Principle Versus Pooled ANOVA”.
Novum welcomes the opportunity to speak with those interested in learning more about our full range of services. Email firstname.lastname@example.org for more information.
For over 40 years, Novum has been considered one of the world’s leaders in the conduct of clinical trials; Early Phase Research from First in Human studies to large bioequivalence studies are conducted at Clinical Pharmacology units in Houston, Texas; Las Vegas, Nevada; and Fargo, North Dakota. A separate division, managing Late Phase Research requiring patient populations across multiple therapeutic areas, is lead by the Clinical Trials Division headquartered in Pittsburgh, Pennsylvania.